Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03034811 · ClinicalTrials.gov registry record · NA

Persona Partial Knee Clinical Outcomes Study

A NA study of Osteoarthritis and Avascular Necrosis, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
643
Enrollment target
20
Study locations

NCT03034811: Active NA study of Osteoarthritis and Avascular Necrosis, sponsored by Zimmer Biomet.

NCT03034811 is a NA study of Osteoarthritis and Avascular Necrosis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 643 participants, below the 813-participant average among 135 other Osteoarthritis trials with a reported enrollment target (21% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03034811, a NA study of Osteoarthritis and Avascular Necrosis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
643 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System.

Primary Outcome

A Patient reported functional outcome score for knee arthroplasty

Interventions

  • DEVICE Persona Partial Knee system

Study Locations (20)

Other

  • Orthopädisches Spital Speising - Vienna
  • Cliniques Universitaires Saint-Luc - Woluwe-Saint-Lambert
  • Marseille University-Hospital Centres - Marseille
  • Public Hospital of Versailles - Versailles
  • Hessing Stiftung - Augsburg
  • Sana Kliniken Sommerfeld - Berlin
  • Waldkrankenhaus Eisenberg - Eisenberg
  • Orthopedic Institute IRCCS - Milan
  • Fondazione IRCCS Policlinico San Matteo - Pavia
  • Hospital Alcorcón - Madrid
  • Umea University Hospital - Umeå

California

  • Sah Orthopaedic Associates - Fremont

Colorado

  • Panorama Orthopedics & Spine Center - Golden

Illinois

  • Midwest Orthopaedics at Rush - Chicago

Indiana

  • Henry County Orthopedics and Sports Medicine - New Castle

Massachusetts

  • Sports Medicine North - Beverly

Michigan

  • Troy Orthopaedic Associates - Troy

New Mexico

  • New Mexico Orthopaedics - Albuquerque

Trial Details

FieldValue
Enrollment Target 643 participants
Start Date 2017-02-08
Est. Completion 2029-07
Phase NA
Zimmer Biomet

115 total trials

What the registry record for NCT03034811 still lists

NCT03034811 is an interventional study that assigns participants to a tested intervention. The registered 643 participants enrollment target is mid-sized for trials with a published cap, below the 813-participant average among 135 other Osteoarthritis trials with a reported enrollment target (21% lower).

The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Persona Partial Knee system is the first listed.

NCT03034811 names 20 study sites across 10 states, led by Other, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT03034811 about?

NCT03034811 is a clinical study titled "Persona Partial Knee Clinical Outcomes Study". The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System.

What is the current status of trial NCT03034811?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 643 participants. The study started on 2017-02-08. Estimated completion is 2029-07.

What conditions does trial NCT03034811 study?

This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures, Conditional Revision of the Articular Surface.

What interventions are being tested in trial NCT03034811?

The interventions under investigation include: Persona Partial Knee system (DEVICE).

Who is sponsoring clinical trial NCT03034811?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03034811 being conducted?

This trial has 20 study locations across California, Colorado, Illinois, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03034811's enrollment target sits among peer trials

643 22nd of 135 higher than 114 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05146297 · 644 participants · NA

    Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

  • NCT06994442 · 644 participants · Phase 3

    Optimizing Pain Treatment in Children On Mechanical Ventilation

  • NCT05204888 · 642 participants · NA

    myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • NCT07012395 · 645 participants · Phase 2

    A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03034811, the US trial registry maintained by the National Library of Medicine. NCT03034811 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.